A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Arvinas Inc.
Arvinas Inc.
ALX Oncology Inc.
Seagen Inc.
Eli Lilly and Company
Novartis
Var2 Pharmaceuticals
Takeda
Tempus AI
Eli Lilly and Company
Travera Inc
A2 Biotherapeutics Inc.
Palleon Pharmaceuticals, Inc.
Turning Point Therapeutics, Inc.
Apollomics Inc.
Eli Lilly and Company
ModeX Therapeutics, An OPKO Health Company
Hoffmann-La Roche
Compugen Ltd
Tempus AI
Vyriad, Inc.
Intensity Therapeutics, Inc.
PureTech
Eli Lilly and Company
NextCure, Inc.
VitaMed Research LLC
NantCell, Inc.
HiberCell, Inc.
Klus Pharma Inc.
Kineta Inc.
Genzada Pharmaceuticals USA, Inc.
Blue Note Therapeutics
MacroGenics
MacroGenics
SpeciCare
Petra Pharma
Synermore Biologics Co., Ltd.
Amgen
Altor BioScience
INSYS Therapeutics Inc
Calando Pharmaceuticals
Altor BioScience
Pharmacyclics LLC.